Systemic bevacizumab treatment of a juxtapapillary retinal haemangioma

Acta Ophthalmologica Scandinavica

Volumn 85, Issue 1, 2007, Pages 114-116

  von Buelow, Maximilian ^a   Pape, Stefanie ^a   Hoerauf, Hans ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; BEVACIZUMAB; TRIAMCINOLONE ACETONIDE;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CASE REPORT; CLINICAL FEATURE; EXUDATE; FLUORESCENCE ANGIOGRAPHY; HEMANGIOMA; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; OPHTHALMOSCOPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REPEATED DRUG DOSE; RETINA CAPILLARY; RETINA DETACHMENT; RETINA EDEMA; RETINA TUMOR; TUMOR REGRESSION; TUMOR VOLUME; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FLUORESCEIN ANGIOGRAPHY; HEMANGIOMA, CAPILLARY; HUMANS; MALE; MIDDLE AGED; RETINAL NEOPLASMS; RETREATMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846428410     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2006.00825.x     Document Type: Article

References (5)

1. Aiello LP, George DJ, Cahill MT, Wong JS, Cavallerano J, Hannah AL & Kaelin WG (2002): Rapid and durable recovery of visual function in a patient with von Hippel-Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor SU5416. Ophthalmology 109: 1745-1751.
2. Garcia-Arumi J, Sararols LH, Cavero L, Escalada F & Corcóstegui BF (2000): Therapeutic options for capillary papillary haemangiomas. Ophthalmology 107: 48-54.
3. Girmens JF, Erginay A, Massin P, Scigalla P, Gaudric A & Richard S (2003): Treatment of von Hippel-Lindau retinal haemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular oedema than for haemangioblastomas. Am J Ophthalmol 136: 194-196.
4. Madhusudan S, Deplanque G, Braybrooke JP et.al. (2004): Antiangiogenic therapy for von Hippel-Lindau disease. JAMA 291: 943-944.
5. Schmidt-Erfurth U, Kusserow C, Barbazetto IA & Laqua H (2002): Benefits and complications of photodynamic therapy of papillary capillary haemangiomas. Ophthalmology 109: 1256-1266.